An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

The World Health Organization aims to reduce TB cases by 80% by 2030. The United Kingdom reported a 13% rise in TB cases in ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...

Learn how new TB treatments show higher success rates and fewer side effects with shorter, all-oral regimens. Discover more.

Apr. 21, 2025 — An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler ...

This would shorten treatment for most people ... ultrasensitive RNA-based tests for malaria. TB, however, presented new technical challenges that first had to be overcome for the test to be ...

Day on March 24 was started to create awareness among people about a chronic, sinister but totally curable disease. Before, T.B. was considered a death warrant. But the discovery of the first anti-TB.

This treatment is given when TB is either resistant to rifampicin, a critical first-line drug, or rifampicin and isoniazid, another first-line drug combination. These resistant strains are ...

In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...